Shanghai (Reuters)-The state news agency Xinhua reported on Saturday evening that China’s top legislature passed a new biosafety law aimed at preventing and managing infectious diseases.
According to Xinhua News Agency, the Standing Committee of the National People’s Congress voted to pass the law on Saturday, which will take effect on April 15, 2021.
The law will establish a biosafety risk prevention and control system, including risk monitoring and early warning, risk investigation and assessment, and information sharing.
According to Xinhua News Agency, it will also have regulations to prevent and respond to specific biosafety risks, including major emerging infectious diseases, epidemics and emergencies, as well as the research, development and application of biotechnology.
China announced in May that its goal was to quickly pass the biosafety law before the end of the year shortly after the global coronavirus outbreak, which was first discovered in Wuhan, China.
After taking active measures to contain its spread, China has managed to contain the spread of the coronavirus in the country. Last week, a new case of infection was detected in the eastern coastal city of Qingdao. However, China did not report a local case for about two months, thus ending the epidemic.
The most recent report of the Chinese Health Commission was on October 1
(Reporting by Emily Chow; Editing by Raju Gopalakrishnan)